Halofantrine and acute intravascular haemolysis

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2024

Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020

Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2020

Genomically-guided therapies: A new era for cystic fibrosis.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2019

Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis.

The Journal of hospital infection·2018

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Journal of clinical pharmacology·2026

Hyaluronic Acid in the Management of Foot and Ankle Pathologies.

Foot & ankle specialist·2026

Audit and Evaluation of the Effect of Fresh Frozen Plasma and Adjunct Pharmacological Agents (Vitamin K1, Prothrombin Complex Concentrate, Tranexamic Acid, and Recombinant Factor VIIa) on Pre- and Post- Transfusion INR in Patients with Coagulopathy: A Prospective Study.

Journal of pharmacy & bioallied sciences·2026

Temporal phosphoproteomics reveals key regulators of procoagulant COAT platelet generation.

Blood vessels, thrombosis & hemostasis·2026

Molecular control of platelet extravasation into tumors and its impact on tumor growth.

Blood vessels, thrombosis & hemostasis·2026

Augmenting hemopexin-mediated heme scavenging mitigates sepsis-induced acute kidney injury in humanized sickle cell mice.

Blood vessels, thrombosis & hemostasis·2026

Related Experiment Videos

Halofantrine and acute intravascular haemolysis

Related Concept Videos

ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals.

Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.

Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Genomically-guided therapies: A new era for cystic fibrosis.

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients.

Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions.

Hyaluronic Acid in the Management of Foot and Ankle Pathologies.

Audit and Evaluation of the Effect of Fresh Frozen Plasma and Adjunct Pharmacological Agents (Vitamin K1, Prothrombin Complex Concentrate, Tranexamic Acid, and Recombinant Factor VIIa) on Pre- and Post- Transfusion INR in Patients with Coagulopathy: A Prospective Study.

Temporal phosphoproteomics reveals key regulators of procoagulant COAT platelet generation.

Molecular control of platelet extravasation into tumors and its impact on tumor growth.

Augmenting hemopexin-mediated heme scavenging mitigates sepsis-induced acute kidney injury in humanized sickle cell mice.

Related Experiment Videos

Halofantrine and acute intravascular haemolysis

Related Concept Videos

Related Articles